PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574932
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574932
Dengue Testing Market size was valued at USD 638.90 million in 2023, expanding at a CAGR of 6.20% from 2024 to 2032.
The dengue testing market focuses on diagnosing dengue fever, a viral illness transmitted by mosquitoes. This market includes various testing methods, such as blood tests and rapid diagnostic tests, that help identify the virus in patients. The demand for these tests is growing due to rising dengue cases worldwide. Healthcare providers use these tests to ensure timely treatment and control outbreaks. Companies in this market develop new and better testing technologies to improve accuracy and speed. Overall, the dengue testing market plays a crucial role in managing public health and preventing the spread of the disease.
Dengue Testing Market- Market Dynamics
Rising global travel increases dengue exposure, boosting demand for Dengue testing
Rising global travel is a major driver for the dengue testing market. As more people travel to regions where dengue is common, the chances of exposure to the virus increase. This leads to a higher demand for dengue testing to quickly diagnose and treat the disease.
According to the World Health Organization (WHO), the incidence of dengue has increased dramatically in recent decades, with an estimated 390 million infections each year (WHO, 2023). This statistic highlights the growing need for effective testing and monitoring solutions. As more travelers visit affected areas, health authorities are focusing on expanding testing services to ensure timely responses and better public health outcomes.
Dengue Testing Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.20% over the forecast period (2024-2032)
Based on Test type segmentation, ELISA-based Tests was predicted to show maximum market share in the year 2023
Based on End User segmentation, Hospitals was the leading type in 2023
Based on Region, Asia Pacific was the leading revenue generator in 2023
The Global Dengue Testing Market is segmented based on Test Type, End User, and Region.
The market is divided into three categories based on Test type: ELISA-based Tests, RT-PCR-based Tests, Dengue IgG/IgM Rapid Tests, and others. ELISA-based Tests are the most prominent segment. They are widely used due to their ability to detect antibodies in the blood, making them effective for diagnosing dengue infections. These tests are not only reliable but also relatively easy to perform, allowing for quick results. Their high sensitivity and specificity contribute to their popularity among healthcare providers. Overall, ELISA tests play a crucial role in managing and controlling dengue outbreaks.
The market is divided into two categories based on End User: Hospitals, Diagnostic Centers, and Others. Hospitals are the most prominent segment. They play a crucial role in diagnosing and treating dengue cases, as they have access to advanced testing facilities and skilled healthcare professionals. Hospitals can provide comprehensive care, including immediate treatment for severe cases. Their ability to handle emergencies and offer a wide range of services makes them essential in managing dengue outbreaks. This importance leads to a higher demand for testing in hospital settings.
Dengue Testing Market- Geographical Insights
The Asia Pacific region is crucial to the dengue testing market. Countries like India, Thailand, and Indonesia have high rates of dengue, which drives the demand for effective testing solutions. Rapid test kits and molecular diagnostics are favored for their speed and accuracy. Local manufacturers are emerging, providing affordable options that meet the needs of developing markets.
Governments and health organizations are raising awareness and improving testing infrastructure. There is also growing collaboration with international companies, enhancing access to advanced technologies. Overall, the diverse healthcare landscape in this region offers many opportunities for innovation and growth in dengue testing.
The dengue testing market features several key players, each offering unique diagnostic solutions. Abbott Laboratories and BD provide advanced rapid test kits known for their reliability. Roche Diagnostics specializes in high-quality molecular testing, ensuring accurate results. Bio-Rad Laboratories focuses on serological tests to detect dengue antibodies, while Seegene Inc. offers multiplex tests for various viruses.
MedMira Inc. offers quick-result rapid tests, and Cepheid delivers fast and precise molecular diagnostics. Mylab Discovery Solutions and Sanjivani Paramedical Pvt. Ltd. cater to emerging markets with affordable options. Hologic Inc. and Thermo Fisher Scientific round out the market with a diverse range of testing Tests. Overall, these companies compete by emphasizing speed, accuracy, and cost-effectiveness to address the growing need for dengue diagnostics.
In June 2023, Roche Diagnostics launched a new multiplex PCR test designed to simultaneously detect dengue, Zika, and chikungunya viruses. This advancement aims to enhance differential diagnosis in areas where these diseases frequently coexist.